110 related articles for article (PubMed ID: 14039067)
1. [The biosynthesis of sparteine].
SCHUETTE HR; BOHLMANN F; REUSCHE W
Arch Pharm Ber Dtsch Pharm Ges; 1961 Oct; 294/66():610-5. PubMed ID: 14039067
[No Abstract] [Full Text] [Related]
2. Sparteine oxidation by the human liver: absence of inhibition by mephenytoin.
Jurima M; Inaba T; Kalow W
Clin Pharmacol Ther; 1984 Mar; 35(3):426-8. PubMed ID: 6697650
[TBL] [Abstract][Full Text] [Related]
3. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.
Eichelbaum M; Spannbrucker N; Steincke B; Dengler HJ
Eur J Clin Pharmacol; 1979 Sep; 16(3):183-7. PubMed ID: 499318
[TBL] [Abstract][Full Text] [Related]
4. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
Ishizaki T; Eichelbaum M; Horai Y; Hashimoto K; Chiba K; Dengler HJ
Br J Clin Pharmacol; 1987 Apr; 23(4):482-5. PubMed ID: 3580254
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.
Mikus G; Ha HR; Vozeh S; Zekorn C; Follath F; Eichelbaum M
Eur J Clin Pharmacol; 1986; 31(1):69-72. PubMed ID: 3780830
[TBL] [Abstract][Full Text] [Related]
6. The genetic polymorphism of sparteine metabolism.
Eichelbaum M; Reetz KP; Schmidt EK; Zekorn C
Xenobiotica; 1986 May; 16(5):465-81. PubMed ID: 3739368
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquine.
Otton SV; Inaba T; Mahon WA; Kalow W
Can J Physiol Pharmacol; 1982 Jan; 60(1):102-5. PubMed ID: 7066751
[TBL] [Abstract][Full Text] [Related]
8. The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.
Evans DA; Harmer D; Downham DY; Whibley EJ; Idle JR; Ritchie J; Smith RL
J Med Genet; 1983 Oct; 20(5):321-9. PubMed ID: 6644761
[TBL] [Abstract][Full Text] [Related]
9. Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistry.
Tyndale RF; Gonzalez FJ; Hardwick JP; Kalow W; Inaba T
Pharmacol Toxicol; 1990 Jul; 67(1):14-8. PubMed ID: 2395811
[TBL] [Abstract][Full Text] [Related]
10. [A human genetic defect in the metabolism of sparteine].
Spannbrucker N; Eichelbaum M; Steinke B; Dengler HJ
Verh Dtsch Ges Inn Med; 1978; (84):1125-7. PubMed ID: 741903
[No Abstract] [Full Text] [Related]
11. New mammalian metabolites of sparteine.
Chaudhuri A; Keller WJ
Life Sci; 1990; 47(4):319-25. PubMed ID: 2388532
[TBL] [Abstract][Full Text] [Related]
12. Deficient metabolism of debrisoquine and sparteine.
Inaba T; Otton SV; Kalow W
Clin Pharmacol Ther; 1980 Apr; 27(4):547-9. PubMed ID: 7357813
[TBL] [Abstract][Full Text] [Related]
13. A simple borohydride/GC method for measuring sparteine metabolites in man.
Inaba T; Vinks A; Otton SV
Br J Clin Pharmacol; 1986 May; 21(5):473-80. PubMed ID: 3718806
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacogenetics of sparteine and debrisoquine.
Inaba T; Vinks A; Otton SV; Kalow W
Clin Pharmacol Ther; 1983 Mar; 33(3):394-9. PubMed ID: 6825393
[TBL] [Abstract][Full Text] [Related]
15. Influence of the defective metabolism of sparteine on its pharmacokinetics.
Eichelbaum M; Spannbrucker N; Dengler HJ
Eur J Clin Pharmacol; 1979 Sep; 16(3):189-94. PubMed ID: 499319
[TBL] [Abstract][Full Text] [Related]
16. The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.
Meyer UA; Skoda RC; Zanger UM
Pharmacol Ther; 1990; 46(2):297-308. PubMed ID: 2181495
[TBL] [Abstract][Full Text] [Related]
17. [Stereospecific hydroxylation of (+)-sparteine (pachycarpine) in the rat].
Ebner T; Eichelbaum M; Fischer P; Meese CO
Arch Pharm (Weinheim); 1989 Jul; 322(7):399-403. PubMed ID: 2783013
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities.
Eichelbaum M; Bertilsson L; Säwe J; Zekorn C
Clin Pharmacol Ther; 1982 Feb; 31(2):184-6. PubMed ID: 7056024
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.
Lennard MS
Pharmacol Toxicol; 1990 Oct; 67(4):273-83. PubMed ID: 2077517
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs.
Otton SV; Inaba T; Kalow W
Life Sci; 1983 Feb; 32(7):795-800. PubMed ID: 6827912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
